Status:

COMPLETED

Effectiveness of Motivational Interviewing on Improving Care for Type 2 Diabetes Mellitus Patients in China

Lead Sponsor:

The University of Hong Kong-Shenzhen Hospital

Conditions:

Diabete Type 2

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The International Diabetes Federation estimated that there were nearly 110 million diabetes mellitus (DM) patients in China, which was the highest number recorded in the world. In response to the risi...

Detailed Description

This RCT was implemented from May 2016 to April 2017 in Shenzhen, China. Shenzhen is the fourth-biggest city in China, with a rapidly expanding population of 12 million people and the highest GDP in t...

Eligibility Criteria

Inclusion

  • Type 2 diabetes with HbA1c between 7-10%
  • 18-75 years old
  • No known severe comorbidities or complications, such as cancer, unstable angina, frequent exacerbation of chronic obstructive pulmonary disease, or diabetic retinopathy
  • Cognitively competent enough to understand written and the oral expression of the language native to the study site

Exclusion

  • Known severe comorbidities or complications, such as cancer, unstable angina, frequent exacerbation of chronic obstructive pulmonary disease, or diabetic retinopathy
  • Illiterate, or cognitively competent enough to understand written and the oral expression of the language native to the study site

Key Trial Info

Start Date :

May 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 26 2019

Estimated Enrollment :

225 Patients enrolled

Trial Details

Trial ID

NCT04120844

Start Date

May 1 2016

End Date

September 26 2019

Last Update

October 9 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Effectiveness of Motivational Interviewing on Improving Care for Type 2 Diabetes Mellitus Patients in China | DecenTrialz